| P50 | author | Tim J Schulz | Q54298437 |
| | Evert M van Schothorst | Q57320816 |
| | Mario Ost | Q57330656 |
| | Verena Coleman | Q59613692 |
| | Martin Jastroch | Q63869059 |
| | Jaap Keijer | Q37317104 |
| | Anna Patricia Kipp | Q40818218 |
| | Susanne Klaus | Q40818248 |
| | Susanne Keipert | Q42209763 |
| P2093 | author name string | Anja Voigt | |
| | Inge van der Stelt | |
| | Antonia Graja | |
| | Sebastian Ringel | |
| | Thomas Ambrosi | |
| P2860 | cites work | Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine | Q63609769 |
| | The browning of white adipose tissue: some burning issues | Q87586436 |
| | BetaKlotho is required for metabolic activity of fibroblast growth factor 21 | Q24681531 |
| | Inventing new medicines: The FGF21 story | Q26823319 |
| | Stressed Liver and Muscle Call on Adipocytes with FGF21 | Q27014973 |
| | Non-invasive quantification of white and brown adipose tissues and liver fat content by computed tomography in mice | Q28483774 |
| | A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis | Q28588558 |
| | Mitochondria: in sickness and in health | Q29614825 |
| | Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 |
| | Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 | Q29615209 |
| | AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha | Q29620443 |
| | β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors | Q33596037 |
| | NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism | Q34054078 |
| | hNAG-1 increases lifespan by regulating energy metabolism and insulin/IGF-1/mTOR signaling | Q34217628 |
| | Quercetin decreases high-fat diet induced body weight gain and accumulation of hepatic and circulating lipids in mice. | Q34232744 |
| | FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. | Q34315567 |
| | Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice | Q34350772 |
| | Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3 | Q34372265 |
| | Brown and beige fat: development, function and therapeutic potential | Q34375850 |
| | Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans | Q34403054 |
| | Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. | Q34472039 |
| | Dietary effects on body composition, glucose metabolism, and longevity are modulated by skeletal muscle mitochondrial uncoupling in mice | Q34588386 |
| | Fibroblast growth factor 21 corrects obesity in mice | Q34805555 |
| | Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs | Q35135414 |
| | Activation of AMPKα2 is not crucial for mitochondrial uncoupling-induced metabolic effects but required to maintain skeletal muscle integrity | Q35147707 |
| | FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis | Q35755169 |
| | Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes | Q35784028 |
| | High-fat diet and FGF21 cooperatively promote aerobic thermogenesis in mtDNA mutator mice | Q35865700 |
| | Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans | Q35929501 |
| | Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity | Q36040443 |
| | BIOCLAIMS standard diet (BIOsd): a reference diet for nutritional physiology | Q36049521 |
| | Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. | Q36953853 |
| | FGF21 is an Akt-regulated myokine | Q37017459 |
| | Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease | Q37153759 |
| | Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle | Q37380152 |
| | Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia | Q37429196 |
| | Interplay between FGF21 and insulin action in the liver regulates metabolism | Q37524205 |
| | AMPK activation of muscle autophagy prevents fasting-induced hypoglycemia and myopathy during aging | Q37583673 |
| | Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies | Q37607682 |
| | Adipose tissue browning and metabolic health | Q38154504 |
| | Endocrine aspects of organelle stress—cell non-autonomous signaling of mitochondria and the ER. | Q38354015 |
| | Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway | Q38890792 |
| | Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine | Q39042458 |
| | The TGF-β superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. | Q39492314 |
| | FGF21 reloaded: challenges of a rapidly growing field | Q39798117 |
| | Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. | Q40056643 |
| | Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. | Q40958865 |
| | Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion | Q41810632 |
| | The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue | Q41912342 |
| | Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. | Q42813296 |
| | Mitochondrial myopathy induces a starvation-like response | Q42959191 |
| | Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia | Q42989201 |
| | Ketogenic diet slows down mitochondrial myopathy progression in mice | Q43157369 |
| | UCP1 ectopically expressed in murine muscle displays native function and mitigates mitochondrial superoxide production | Q43230676 |
| | Skeletal muscle uncoupling-induced longevity in mice is linked to increased substrate metabolism and induction of the endogenous antioxidant defense system | Q43810687 |
| | Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice | Q44504595 |
| | Stress heats up the adipocyte | Q44675162 |
| | Expression of uncoupling protein 1 in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation | Q45248711 |
| | Uncoupling protein 1 expression in murine skeletal muscle increases AMPK activation, glucose turnover, and insulin sensitivity in vivo | Q46694633 |
| | Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans | Q46770146 |
| | Functional thermogenic beige adipogenesis is inducible in human neck fat. | Q50937141 |
| | FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. | Q51016978 |
| | Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. | Q51379603 |
| | Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles. | Q51407654 |
| | Autophagy is required to maintain muscle mass. | Q51411361 |
| | Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. | Q51421300 |
| | Muscle mitohormesis promotes cellular survival via serine/glycine pathway flux. | Q51676138 |
| | A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. | Q51709332 |
| | Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. | Q51725499 |
| | Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue. | Q53514538 |
| P433 | issue | 2 | |
| P304 | page(s) | 79-90 | |
| P577 | publication date | 2015-11-24 | |
| P1433 | published in | Molecular Metabolism | Q27724805 |
| P1476 | title | Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action | |
| P478 | volume | 5 | |